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• Introduction – Life Cycle Assessment (LCA) 
• Past, current and future LCAs 
• General results and discussion 
Introduction – Life Cycle Assessment (LCA) 
 
Introduction: Our external environment 
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EARTHWARDS™ strives to improve the environmental 
performance of a product by 
Reducing materials, energy, water and waste 
Utilizing safer chemicals 
Developing more efficient packaging 
Driving innovation 
 
Introduction: Life Cycle Assessment (LCA) 
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• Assessment of the potential environmental impact of a given 
product or service within the production chain and 
throughout its lifespan 
 
1. Goal and scope definition 
2. Life Cycle Inventory (LCI) 
3. Life Cycle Impact Assessment (LCIA) 
4. Interpretation 
Areas of Protection (AoP): 
1. Natural Resources 
2. Human Health 
3. Ecosystem quality 
Driver of industrial production/consumption: 
Resources 
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• Correlation between resource use and other environmental 
impacts  
• Need for a more holistic view on technology and environment: 
– not only end-of-pipe 
– complete supply chain 
– preventive rather than clean-up 
– act pro-actively through resource management 
– direct link with economic potential 
 
 
What with the resources? 
Exergy Analysis 
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Life Cycle Assessment – What with the resources? 
Exergetic LCA 
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• Combination of Process Analysis (EA) and Exergetic Life Cycle 
Analysis (ELCA) 
– Identification, localization and reduction of environmental burdens 
OVERALL INDUSTRIAL ENVIRONMENTAL PROCESSES (at supplier)
(Industrial level, cradle-to-gate γ)
PLANT SPECIFIC SUPPORTING CORE PROCESSES (at plant)



























































Past, current and future Projects 
Past, current and future Projects 
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API ELCA Cases 
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• Assess environmental sustainability (“greenness”) and resource 
consumption of API synthesis steps of: 
– Domperidone (10 steps) 
– Ketoconazole (8 steps) 
– Levocabastine (8 steps) 
– Mitratapide (7 steps) 
– Risperidone (7 steps) 
• 1-9 GJex/mole API  eq. 250-2250 km transport family car 
• 65% of resource extraction of API production due to fossil 
resources at the cradle 
• 45% of resource losses occur at JNJ plant Geel (BE), 55% through 
supply chain 

























































API ELCA Cases 
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• New (preliminary): correlation models to predict resource 
extraction due to API synthesis steps based on 3 process 
dependend parameters: 
– Organic Solvent Use 
– # Reactors 




























API ELCA Cases: Galantamine generations 
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• Comparative environmental sustainability assessment of 3 
generations of Galantamine 
• +- 41% reduction in integral resource consumption 1st  
3rd generation 

























(toluene as solvent)  
Second generation 



























Van der Vorst et al., 2013. Green Chemistry. 
API ELCA Cases: Galantamine generations 
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• Resource consumption reduction of Galantamine synthesis 
steps (MJex/mole intermediate) 
41% 
2nd 3rd 
Van der Vorst et al., 2013. Green Chemistry. 
Past, current and future Projects 
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DP ELCA Cases 
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• Full life cycle evaluation of Galantamine.HBr (Reminyl®, 
prolonged release capsules) 
• Batch versus continuous Drug Product (DP) Production? The case 
of Tramacet® 
• Upscaling of R&D to manufacturing batch sizes in DP Production: 
impact on the resource footprint 
 
Tramacet 
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Exergetic sustainability 
assessment of batch versus 
continuous wet granulation 
based pharmaceutical tablet 
manufacturing: a cohesive 
analysis at three different levels  
De Soete et al., 2013. Green Chemistry. 
Tramacet DP Production 
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Process Plant Life Cycle 
De Soete et al., 2013. Green Chemistry. 
Tramacet: what about the supply chain? 










AND ON-SITE UTILITY 
PROCESSES
PACKAGING
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Tramacet: what about the supply chain? 
De Soete et al., 2013.  
Green Chemistry. 
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Reminyl: what about the supply chain? 
Olen + Latina Processes 
Tramacet Results 
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• ConsiGma™ huge step forward towards Greener Formulation 
Processes 
• Further reduce impact through: 
– In-line blending and in-line coating 
– Re-using treated wastewater for cooling or cleaning purposes 
– Recycling exhaust air for heating purposes 
• Sensitive parameters: 
– API dosage 
– # tablets per folding box (packaging) 
 
De Soete et al., 2013. Green Chemistry. 
Prezista 
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• Environmental Resource Footprinting of Drug Manufacturing: 
1. Effects of Scale up (WG1  WG5  WG30  WG240) 
2. Effects of Tablet Dosage (2x400mg tablet vs 1x800mg tablet) 
 
 
De Soete et al. Resources, Conservation and Recycling. 
Prezista: effects of scale-up 
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Increasing batch scale  
Prezista: effects of tablet dosage  
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• More efficient at higher scale, mainly due to use of better 
performing cleaning procedures (e.g. CIP) and use of resource 
efficient equipment  
• In meeting social and economic demands by launching the 
PREZISTA® 800 mg tablet, no trade-off in environmental burden 
occurred 
– Resources for extra granulation step cancelled out by more efficient 
packaging phase 
De Soete et al. Resources, Conservation and Recycling. 
Carbon Footprinting 
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• Carbon Footprinting of Durogesic® 
– Deloitte 
– Patch + primary and secondary packaging: 
+- 50% of total footprint 
• Risperdal Consta® and Xeplion® Carbon Footprint 
– BestFootForward (BFF) 
 
Carbon Footprinting: Durogesic 
(PE International) 
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Current and future projects 
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• Environmental sustainability assessment of Janssen 
Pharmaceutica catering and hospitality services 
   




• Balancing positive and negative human toxicity effects of 
pharmaceutical production processes 
 
Past, current and future Projects 
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Development of a Generic Screening Tool to be used 
in Environmental Sustainability Assessment of 
Pharmaceutical Formulations 




Upstream Operations: Drug Discovery/
Development
             Manufacturing

































SUSTAINABLE SUPPLY CHAIN MANAGEMENT
SUSTAINABLE LIFE CYCLE MANAGEMENT
Time
ANTICIPATE on Environmental 





General Results and Discussion 
 
Results overview and future outlook 
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• Substantial knowledge on environmental impact of API synthesis 
processes 
• Dosage Forms: case specific; Product Category level too 
aggregated 
• Need to move downstream in supply chain: what about 
distribution networks? Logistics? Use phase? Waste management? 
• Take into account other impacts as well (‘Human Health’, PEF 
impact categories) 




Thank You ! 
Janssen Pharmaceutica 
PDMS – Technical Operations - EHS² 
